What Medline's latest 10-Q says: 8 signals

Medline filed its latest 10-Q with the SEC on Aug 5, 2026. It discusses cash flow concern, debt refinancing and governance change.

Public (MDLN)Medical Equipment Manufacturing10,000+ employeesmedline.comLinkedIn

Filed: Aug 5, 2026
Filings: 2
Signals: 16

10-Q · latest 10

What Medline's 10-Q filings say

10-Q
Filed Aug 5, 2026 · 8 signals
SEC EDGAR
- Governance changeNeutral
  EVP of Supply Chain, William Abrams, adopts plan to sell up to 1.14M shares.
  William J. Abrams, EVP of Supply Chain Solutions, adopted a 10b5-1 trading plan on May 26, 2026, to sell up to 1,139,433 shares.
- Logistics challengeNeutral
  Medline managing complex $279M tariff refund and associated customer repayments.
  A new $279 million receivable from an IEEPA tariff refund is creating operational complexity, requiring the company to also manage and process repayments back to its customers.
  $279M
  IEEPA tariff refund receivable
- Debt refinancingNeutral
  Medline refinanced its term loan facility and issued new debt notes in Q2 2026.
  The company actively managed its capital structure by issuing new 2031 and 2033 Senior Secured Notes and refinancing its dollar-denominated term loan.
  $12.8B
  Total indebtedness as of June 27, 2026
  Bank of America, N.A.
- Cash flow concernNegative
  Medline faces a potential $10.25B liability from its Tax Receivable Agreement (TRA).
  The company's complex corporate structure includes a Tax Receivable Agreement (TRA) with a recorded liability of $4.4B, which could grow to $10.25B.
  $10.3B
  Potential future liability from Tax Receivable Agreement
- Legacy modernizationNeutral
  Medline completes major debt refinancing, issuing new 2031 & 2033 notes.
  The company recently refinanced its existing term loan facility and issued new senior secured notes, a complex transaction that could trigger a review of their treasury and financial management systems.
  Bank of America, N.A.Wilmington Trust, National Association
- Litigation materialNegative
  Company cash flow impacted by $166M payment for a litigation accrual.
  In the prior year period, the company's cash flow from operations was significantly impacted by a $166 million payment for a litigation accrual.
  $166M
  Payment of a litigation accrual
- Inventory issueNegative
  Medline's prior year results show a $160M increase in inventory, indicating potential ongoing challenges.
  In the same period last year, the company's cash flow was negatively impacted by a $160 million increase in inventories.
  $160M
  Increase in inventories in prior year period
10-Q
Filed May 6, 2026 · 8 signals
SEC EDGAR
- Automation investmentPositive
  Medline earmarks $500M for CapEx in 2026, focusing on automation and facility expansion.
  The company plans significant investment in automating distribution centers and expanding manufacturing facilities.
  $500M
  Anticipated net capital expenditures for fiscal year 2026
  automation
- Capacity constraintNegative
  Sales growth strains working capital, tying up $188M in receivables and inventory in Q1.
  Rapid sales growth led to a $146M increase in accounts receivable and a $42M increase in inventories, consuming significant cash from operations.
  $188M
  Combined increase in trade accounts receivable ($146M) and inventories ($42M)
- Cash flow concernNegative
  Working capital changes consumed $161M in cash, driven by a $146M increase in accounts receivable
  The company's cash flow is being negatively impacted by a significant increase in trade accounts receivable and inventory.
  $161M
  Net cash used by changes in working capital in Q1 2026

Showing 10 of 16 filing signals. The Signal API returns all of them.

Get them with one API call

Signal API · MCP

Track Medline with the Signal API

One POST /v1/companies/enrich call with medline.com returns Medline 10-Q signals (sec-10q), each with its source. Or ask Claude through MCP.

Start Free1,000 free creditsUse it in Claude via MCP

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"medline.com","signal_types":["sec-10q"],"limit":20}'

Same industry

Questions about Medline 10-Q

When did Medline file its latest 10-Q?

Medline filed its latest 10-Q on Aug 5, 2026. The one before it was filed on May 6, 2026.

What did Medline disclose in its latest 10-Q?

From the filing dated Aug 5, 2026: EVP of Supply Chain, William Abrams, adopts plan to sell up to 1.14M shares.

Where can I read Medline's 10-Q filing?

The full filing is on SEC EDGAR: https://www.sec.gov/Archives/edgar/data/2046386/000204638626000051/mdln-20260627.htm. This page summarizes what the filing says and links to it.

Source. Quarterly reports (Form 10-Q) filed with the SEC. Every card links to the filing on EDGAR.

Method. Insights are extracted from the filing text and grouped by category. Numbers are quoted from the filing.

Data as of Sep 30, 2026.

How this data is built →Get it from the Signal API →

What Medline's latest 10-Q says: 8 signals

What Medline's 10-Q filings say

Track Medline with the Signal API

10-Q at related companies

Questions about Medline 10-Q